Drug Profile
ABB
Alternative Names: Agkistrodon blomhoffii blomhoffii boie; MamushiLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antihyperglycaemics; Hepatoprotectants
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetes mellitus; Gastric ulcer; Liver disorders
Most Recent Events
- 15 Sep 1999 Profile reviewed, but no significant changes made
- 04 Feb 1997 New profile
- 04 Feb 1997 Preclinical development for Diabetes mellitus in Japan (PO)